Provided by Tiger Fintech (Singapore) Pte. Ltd.

CARSGEN-B

21.650
-2.100-8.84%
Volume:3.54M
Turnover:78.84M
Market Cap:12.47B
PE:-13.77
High:23.800
Open:23.750
Low:21.350
Close:23.750
Loading ...

CARsgen Therapeutics Says H1 Loss to Narrow Year Over Year

MT Newswires Live
·
25 Jul

BRIEF-Carsgen Therapeutics Sees Net Loss Not More Than RMB80 Million In HY

Reuters
·
25 Jul

CARsgen Therapeutics Expects Significant Reduction in Net Loss for First Half of 2025

Reuters
·
25 Jul

CARsgen Therapeutics - Reduction in Loss Due to Ct053 Commercialization and Reduced R&D

THOMSON REUTERS
·
25 Jul

CARsgen Therapeutics Sees Net Loss Not More Than RMB80 Mln in Hy

THOMSON REUTERS
·
25 Jul

HK Movers | Biotechnology Stocks Jump With MicroPort up 20%

Tiger Newspress
·
24 Jul

CARsgen Therapeutics Holdings Ltd. Announces New Research Results on SATRI-CEL for Pancreatic Cancer Adjuvant Therapy to be Presented at ESMO Congress 2025

Reuters
·
22 Jul

When Can We Expect A Profit From CARsgen Therapeutics Holdings Limited (HKG:2171)?

Simply Wall St.
·
19 Jul

CARsgen Therapeutics' New Drug Application for Satricabtagene Autoleucel for Advanced Gastric Cancer Accepted by National Medical Products Administration

Reuters
·
26 Jun

CARsgen Therapeutics Announces Presentation of CT071 Clinical Trial Results for Multiple Myeloma at 2025 EHA Congress

Reuters
·
16 Jun

CARsgen Therapeutics Receives Breakthrough Therapy Designation and Priority Review for Satri-cel in Advanced Gastric Cancer Treatment

Reuters
·
02 Jun

CARsgen Therapeutics' Satricabtagene Autoleucel Granted Priority Review by China's NMPA for Advanced Gastric Cancer Therapy

Reuters
·
28 May

CARsgen Therapeutics Holdings Ltd. Conducted Annual General Meeting

Reuters
·
22 May

BUZZ-CARsgen Therapeutics hits nearly 11-week high on share buyback plan

Reuters
·
13 May

BRIEF-Carsgen Therapeutics To Repurchase Shares Not Exceeding 1% Of Total Issued Shares In Open Market

Reuters
·
13 May

CARsgen Therapeutics Completes Buyback of 4,135,500 Shares at HK$24,116,134.85

Reuters
·
13 May

CARsgen Therapeutics Widens Loss in 2024

MT Newswires Live
·
19 Mar

Press Release: CARsgen Announced 2024 Annual Results

Dow Jones
·
19 Mar

BRIEF-CARsgen Therapeutics Says Net Loss Was Around RMB798 Mln For Year

Reuters
·
18 Mar

Carsgen Therapeutics Posts FY Net Income RMB -798 Mln

Reuters
·
18 Mar